Cash Position and Capital Allocation
Net cash provided by operating activities of $47.6 million for the quarter ended June 30, 2019 compared to $34.6 million for the quarter ended June 30, 2018. The year-over-year increase in cash provided by operating activities was largely due to an increase in cash collected resulting from higher revenues compared to the prior year quarter, which was partially offset by an increase in compensation-related costs.
During the quarter, the Company repurchased 579,771 shares of its common stock at an average price per share of $83.34 for a total cost of $48.3 million. As of June 30, 2019, approximately $102.4 million remained available for stock repurchases under the Company’s $400.0 million stock repurchase authorization.
Cash and cash equivalents of $189.1 million at June 30, 2019 compared to $116.6 million at June 30, 2018 and $179.2 million at March 31, 2019. Total debt, net of cash, of $147.1 million at June 30, 2019 compared to $258.4 million at June 30, 2018 and $137.0 million at March 31, 2019. The sequential increase in total debt, net of cash, was primarily due to additional borrowings under the Company’s revolving credit facility.
Second Quarter 2019 Segment Results
Corporate Finance & Restructuring
Revenues in the Corporate Finance & Restructuring segment increased $48.6 million, or 34.4%, to $190.0 million in the quarter compared to $141.4 million in the prior year quarter. Excluding the estimated negative impact from FX, revenues increased $50.9 million, or 36.0%, compared to the prior year quarter. The increase in revenues was primarily due to higher demand for business transformation and transactions and restructuring services coupled with higher success fees. Adjusted Segment EBITDA of $50.5 million, or 26.6% of segment revenues, compared to $35.8 million, or 25.3% of segment revenues, in the prior year quarter. The increase in Adjusted Segment EBITDA was due to higher revenues, which was partially offset by higher compensation, related to an increase in variable compensation and billable headcount and higher SG&A expenses.
Forensic and Litigation Consulting
Revenues in the Forensic and Litigation Consulting segment increased $12.3 million, or 9.2%, to $145.9 million in the quarter compared to $133.5 million in the prior year quarter. Excluding the estimated negative impact from FX, revenues increased $14.0 million, or 10.5%, compared to the prior year quarter. The increase in revenues was primarily due to higher demand for health solutions, construction solutions and disputes services. Adjusted Segment EBITDA of $28.2 million, or 19.4% of segment revenues, compared to $27.6 million, or 20.7% of segment revenues, in the prior year quarter. The increase in Adjusted Segment EBITDA was due to higher revenues, which was partially offset by higher compensation, primarily related to an increase in billable headcount and higher SG&A expenses.
Economic Consulting
Revenues in the Economic Consulting segment increased $22.2 million, or 16.6%, to $155.5 million in the quarter compared to $133.3 million in the prior year quarter. Excluding the estimated negative impact from FX, revenues increased $24.2 million, or 18.2%, compared to the prior year quarter. The increase in revenues was largely due to higher demand for antitrust services in North America and Europe, the Middle East and Africa (“EMEA”). Adjusted Segment EBITDA of $23.3 million, or 15.0% of segment revenues, compared to $15.5 million, or 11.6% of segment revenues, in the prior year quarter. The increase in Adjusted Segment EBITDA was due to higher revenues with improved utilization, which was partially offset by an increase in compensation, primarily related to higher variable compensation.